Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) EBT Margin (2020 - 2025)

Biofrontera has reported EBT Margin over the past 6 years, most recently at 32.98% for Q4 2025.

  • Quarterly results put EBT Margin at 32.98% for Q4 2025, up 4412.0% from a year ago — trailing twelve months through Dec 2025 was 25.2% (up 2233.0% YoY), and the annual figure for FY2025 was 25.2%, up 2232.0%.
  • EBT Margin for Q4 2025 was 32.98% at Biofrontera, up from 95.06% in the prior quarter.
  • Over the last five years, EBT Margin for BFRIW hit a ceiling of 57.34% in Q1 2022 and a floor of 369.31% in Q3 2021.
  • Median EBT Margin over the past 5 years was 60.56% (2022), compared with a mean of 69.13%.
  • Biggest five-year swings in EBT Margin: plummeted -27940bps in 2021 and later surged 30996bps in 2022.
  • Biofrontera's EBT Margin stood at 158.16% in 2021, then skyrocketed by 83bps to 27.44% in 2022, then surged by 221bps to 33.22% in 2023, then tumbled by -134bps to 11.14% in 2024, then skyrocketed by 396bps to 32.98% in 2025.
  • The last three reported values for EBT Margin were 32.98% (Q4 2025), 95.06% (Q3 2025), and 58.73% (Q2 2025) per Business Quant data.